Streptococcus salivarius endophthalmitis and corneal ring infiltrate after intravitreal bevacizumab injection

oc000270 10.3205/oc000270 urn:nbn:de:0183-oc0002705 Case Report Streptococcus salivarius endophthalmitis and corneal ring infiltrate after intravitreal bevacizumab injection Örnek Örnek Kemal K MD

Kırşehir Ahi Evran University School of Medicine, Bağbaşı, Şht. Sahir Kurutluoğlu Cd. No: 100, 40100 Kırşehir Merkez/Kırşehir, TurkeyDepartment of Ophthalmology, School of Medicine, Kırşehir Ahi Evran University, Kırşehir, Turkey

kemalornek@hotmail.com author Erşekerci Erşekerci Tülay Karacan TK MD

Department of Ophthalmology, School of Medicine, Kırşehir Ahi Evran University, Kırşehir, Turkey

author German Medical Science GMS Publishing House

Düsseldorf

610 endophthalmitis corneal ring infiltrate Streptococcus salivarius intravitreal bevacizumab 20260505 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). 2193-1496 16 GMS Ophthalmology Cases GMS Ophthalmol Cases 06 A 65-year-old male patient received intravitreal bevacizumab for age-related macular degeneration. On the first day, he presented with ocular pain, corneal stromal infiltration and dense vitritis. Prompt intravitreal vancomycin and ceftazidime were injected after sampling. Widespread gram-positive cocci were seen on microscopy after staining the vitreous sample. No significant improvement took place the following day and the cornea was completely opacified. The patient underwent an early vitrectomy combined with penetrating keratoplasty. Culture grew Streptococcus salivarius. Postoperative visual acuity was hand motions and the retina was attached. IntroductionBevacizumab is a humanized recombinant monoclonal antibody developed against VEGF-A. It is used intravitreally in the treatment of various retinal diseases. Sight-threatening complications of intravitreal injection include uveitis, retinal tear, rhegmatogenous retinal detachment, traumatic cataract, intraocular hemorrhage, and endophthalmitis. Endophthalmitis has the worst visual prognosis among these. The causative pathogen is mostly bacteria (90%). Eighty percentage of the isolated microorganisms are gram-positive, and the majority are coagulase-negativ</PlainText></TextGroup>e staphylococci <TextLink reference="1"></TextLink>.</Pgraph><Pgraph>Here, we present the first case of rapid onset <Mark2>Streptococcus salivarius</Mark2> endophthalmitis and corneal ring infiltrate after intravitreal bevacizumab injection.</Pgraph></TextBlock> <TextBlock name="Case description" linked="yes"> <MainHeadline>Case description</MainHeadline><Pgraph>A 65-year-old male patient applied to receive his ongoing intravitreal treatment for age-related macular degeneration. Best corrected visual acuity was 7/10 in the right eye and 1/10 in the left eye. He had 1+ nuclear sclerosis in both eyes. There was choroidal neovascularization on the left. Optical coherence tomography imaging revealed subretinal fluid with foveal thickening. Local anesthesia was provided with 0.5% proparacaine drops. The eyelids, eyelashes, and ocular surface were sterilized with povidone-iodine. Then, 0.5 mg/ml intravitreal bevacizumab was injected 4 mm behind the limbus temporally. Topical moxifloxacin drop was initiated after the procedure. </Pgraph><Pgraph>The patient presented with decreased vision and ocular pain on the first day. Visual acuity was hand motions. Slit-lamp examination showed lid swelling, diffuse conjunctival injection, corneal ring infiltrate, anterior chamber cells, vitreous inflammation, and blunted red reflex. There was no hypopyon (Figure 1 <ImgLink imgNo="1" imgType="figure" />). B-Scan ultrasonography revealed dense opacity throughout the vitreous cavity, suggestive of vitritis with attached retina (Figure 2 <ImgLink imgNo="2" imgType="figure" />). The patient was afebrile without any systemic symptoms. He denied any ocular trauma, but had a tooth extracted the day before the injection and was under dental implant treatment. He did not use any systemic antibiotics. </Pgraph><Pgraph>Given the worsening of the vision and presenting clinical findings, immediate vitreous tap was performed and vitreous sample was obtained. Intravitreal 1 mg/0.1 ml vancomycin and 2 mg/0.1 ml ceftazidime were injected after vitreous tap. Medical treatment was planned as hourly fortified ceftazidime and vancomycin eye drops, cyclopentolate 3 times a day and oral ciprofloxacin 75<TextGroup><PlainText>0 m</PlainText></TextGroup>g tablets twice a day.</Pgraph><Pgraph>Microscopic examination and gram staining of the vitreous sample revealed widespread gram-positive cocci. The culture grew a large number of <Mark2>Streptococcus salivarius</Mark2>. The antibiogram showed that the causative pathogen was sensitive to the previously administered intravitreal antibiotics. No significant improvement was observed in the patient’s symptoms and findings, and the keratitis spread to the central tissue and the cornea became completely opaque. Therefore, the patient underwent an early pars plana vitrectomy combined with penetrating keratoplasty. Corneal sample confirmed the <Mark2>Streptococcus salivarius</Mark2> infection. Postoperative visual acuity was hand movements, and the retina was attached. The patient is under close follow-up with intraocular silicone tamponade and corneal graft without any further complications.</Pgraph></TextBlock> <TextBlock name="Discussion" linked="yes"> <MainHeadline>Discussion</MainHeadline><Pgraph>Infectious endophthalmitis is an uncommon complication of intravitreal injection, but when it occurs, the visual outcome can be devastating. Some microorganisms, particularly streptococcus species, tend to be more virulent than others <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>. There are very few reports that implicate <Mark2>Streptococcus salivarius</Mark2> directly in cases of endophthalmitis <TextLink reference="4"></TextLink>, <TextLink reference="5"></TextLink>.</Pgraph><Pgraph>Streptococcus species cause severe endophthalmitis leading to profound vision loss <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>. Kurniawan et al. published the results of patients with streptococcal endophthalmitis, 35.6% of whom applied with hand motions and 42.6% with light perception. Visual acuity was below 20/200 in 77.6% of patients, and 24.7% of eyes received evisceration <TextLink reference="2"></TextLink>. In another series by Kuriyan et al, 75% of eyes had visual acuity below 20/400 and 25% had evisceration <TextLink reference="3"></TextLink>. </Pgraph><Pgraph>Hyperacute endophthalmitis is a severe, rapidly progressing intraocular infection, often presenting within 24 hours, causing severe vision loss and potential loss of the eye. The most common cause is severe infection by gram-negative bacteria (especially <Mark2>Pseudomonas aeruginosa</Mark2>) or <Mark2>Streptococcus pneumoniae</Mark2>. Due to the rapid destruction of intraocular tissues, the prognosis is generally poor and can sometimes lead to blindness or removal of the eye (evisceration). </Pgraph><Pgraph>In a recent study, all cases of intravitreal injection-related endophthalmitis presented with ocular pain, decreased visual acuity and vitritis on average 3.4 days after injection. Only 18 of 23 cases (78%) had a hypopyon <TextLink reference="6"></TextLink>. In this case, there was no hypopyon at the initial examination. The rapid onset of corneal infiltrate and intraocular inflammation, beginning on day 1 after intravitreal injection and causing decreased visual acuity, raised significant clinical concerns. However, there were no history of uveitis and clinical findings of toxic anterior segment syndrome such as increased intraocular pressure, diffuse corneal edema and lack of isolated organisms. </Pgraph><Pgraph><Mark2>Streptococcus salivarius</Mark2> is classified as a member of the <Mark2>viridans streptococci</Mark2> group. It is a commensal bacterium that predominates in the oral cavity of healthy individuals. In this case, the patient had a tooth extraction and dental treatment the day before the injection. Systemic investigations revealed no evidence of infectious pathogens prior to the dental procedures. However, the vitreous culture of the patient grew a large number of <Mark2>Streptococcus salivarius</Mark2>. We assume that the patient may be at risk for <Mark2>Streptococcus salivarius</Mark2> that could have spread from the oral cavity via the bloodstream and contaminated the injection site. Another route of spread could be through conversations between the patient and staff before the injection, which could have led to eye contamination. Therefore, possible spread of bacteria from the neighbouring tissues, high bacterial load which determines disease severity along with virulence factors and host immune response might have caused the very early onset of ocular inflammation in this case. </Pgraph><Pgraph>Corneal ring infiltrate is a ring-shaped stromal infiltrate, circumferential to the limbus, typically leaving a clear zone from it. Ring infiltrates are commonly associated with keratitis caused by Acanthamoeba and fungal keratitis. They are usually present after 24–48 hours of inoculation. Corneal ring infiltrates related to endophthalmitis were described with several infectious agents (<Mark2>Pseudomonas aeruginosa</Mark2>, <Mark2>Staphylococcus aureus</Mark2>), but the most severe cases are associated with <Mark2>Bacillus cereus</Mark2> <TextLink reference="7"></TextLink>, <TextLink reference="8"></TextLink>. Ring infiltration secondary to polymicrobial infection, caused by <Mark2>Streptococcus salivarius</Mark2>, <Mark2>Streptococcus oralis</Mark2>, and a coagulase-negative <Mark2>Staphylococcus</Mark2> sp., has also been reported after postoperative contact lens use <TextLink reference="9"></TextLink>. Here, we present a rare case of corneal ring infiltrate associated with <Mark2>Streptococcus salivarius</Mark2> endophthalmitis following intravitreal bevacizumab injection. </Pgraph></TextBlock> <TextBlock name="Conclusion" linked="yes"> <MainHeadline>Conclusion</MainHeadline><Pgraph>This is the first reported case of rapid onset <Mark2>Streptococcus salivarius</Mark2> endophthalmitis with corneal ring infiltrate after intravitreal bevacizumab injection. Early diagnosis and prompt treatment are critical to prevent devastating consequences. Treatment of post-injection endophthalmitis should be tailored to the individual case depending on the clinical presentation. In such cases, early surgical intervention seems to be preferable. In addition to this, patients who are planned to have intravitreal injections should be informed to postpone dental treatments unless classified as emergency. </Pgraph></TextBlock> <TextBlock name="Notes" linked="yes"> <MainHeadline>Notes</MainHeadline><SubHeadline>Informed consent</SubHeadline><Pgraph>This report was conducted in accordance with the Declaration of Helsinki. Informed consent, including permission for publication of the images included, was provided before the injection.</Pgraph><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing interests.</Pgraph></TextBlock> <References linked="yes"> <Reference refNo="1"> <RefAuthor>Kernt M</RefAuthor> <RefAuthor>Kampik A</RefAuthor> <RefTitle>Endophthalmitis: pathogenesis, clinical presentation, management, and perspectives</RefTitle> <RefYear>2010</RefYear> <RefJournal>Clin Ophthalmol</RefJournal> <RefPage>121-35</RefPage> <RefTotal>Kernt M, Kampik A. Endophthalmitis: pathogenesis, clinical presentation, management, and perspectives. Clin Ophthalmol. 2010;4:121-35. DOI: 10.2147/opth.s6461</RefTotal> <RefLink>https://doi.org/10.2147/opth.s6461</RefLink> </Reference> <Reference refNo="2"> <RefAuthor>Kurniawan ED</RefAuthor> <RefAuthor>Rocke JR</RefAuthor> <RefAuthor>Sandhu SS</RefAuthor> <RefAuthor>Allen PJ</RefAuthor> <RefTitle>Predictors of visual outcome and the role of early vitrectomy in streptococcal endophthalmitis</RefTitle> <RefYear>2018</RefYear> <RefJournal>Clin Exp Ophthalmol</RefJournal> <RefPage>424-31</RefPage> <RefTotal>Kurniawan ED, Rocke JR, Sandhu SS, Allen PJ. Predictors of visual outcome and the role of early vitrectomy in streptococcal endophthalmitis. Clin Exp Ophthalmol. 2018;46(4):424-31. DOI: 10.1111/ceo.13077</RefTotal> <RefLink>https://doi.org/10.1111/ceo.13077</RefLink> </Reference> <Reference refNo="3"> <RefAuthor>Kuriyan AE</RefAuthor> <RefAuthor>Weiss KD</RefAuthor> <RefAuthor>Flynn HW Jr</RefAuthor> <RefAuthor>Smiddy WE</RefAuthor> <RefAuthor>Berrocal AM</RefAuthor> <RefAuthor>Albini TA</RefAuthor> <RefAuthor>Miller D</RefAuthor> <RefTitle>Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes</RefTitle> <RefYear>2014</RefYear> <RefJournal>Am J Ophthalmol</RefJournal> <RefPage>774</RefPage> <RefTotal>Kuriyan AE, Weiss KD, Flynn HW Jr, Smiddy WE, Berrocal AM, Albini TA, Miller D. Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes. Am J Ophthalmol. 2014;157(4):774.e1. DOI: 10.1016/j.ajo.2013.12.026</RefTotal> <RefLink>https://doi.org/10.1016/j.ajo.2013.12.026</RefLink> </Reference> <Reference refNo="4"> <RefAuthor>Mehanna CJ</RefAuthor> <RefAuthor>Kallassi L</RefAuthor> <RefAuthor>Mansour AM</RefAuthor> <RefAuthor>Hamam RN</RefAuthor> <RefTitle>Streptococcus salivarius endogenous endophthalmitis</RefTitle> <RefYear>2021</RefYear> <RefJournal>BMJ Case Rep</RefJournal> <RefPage>e239299</RefPage> <RefTotal>Mehanna CJ, Kallassi L, Mansour AM, Hamam RN. Streptococcus salivarius endogenous endophthalmitis. BMJ Case Rep. 2021;14(2):e239299. DOI: 10.1136/bcr-2020-239299</RefTotal> <RefLink>https://doi.org/10.1136/bcr-2020-239299</RefLink> </Reference> <Reference refNo="5"> <RefAuthor>Weinstein JE</RefAuthor> <RefAuthor>Greven MA</RefAuthor> <RefTitle>Endophthalmitis presentıng as retinal vasculitis less than 24 hours after aflibercept injection: a case report</RefTitle> <RefYear>2022</RefYear> <RefJournal>Retin Cases Brief Rep</RefJournal> <RefPage>685-7</RefPage> <RefTotal>Weinstein JE, Greven MA. Endophthalmitis presentıng as retinal vasculitis less than 24 hours after aflibercept injection: a case report. Retin Cases Brief Rep. 2022;16(6):685-7. DOI: 10.1097/ICB.0000000000001069</RefTotal> <RefLink>https://doi.org/10.1097/ICB.0000000000001069</RefLink> </Reference> <Reference refNo="6"> <RefAuthor>Shah CP</RefAuthor> <RefAuthor>Garg SJ</RefAuthor> <RefAuthor>Vander JF</RefAuthor> <RefAuthor>Brown GC</RefAuthor> <RefAuthor>Kaiser RS</RefAuthor> <RefAuthor>Haller JA</RefAuthor> <RefAuthor> Post-Injection Endophthalmitis (PIE) Study Team</RefAuthor> <RefTitle>Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents</RefTitle> <RefYear>2011</RefYear> <RefJournal>Ophthalmology</RefJournal> <RefPage>2028-34</RefPage> <RefTotal>Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA; Post-Injection Endophthalmitis (PIE) Study Team. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology. 2011;118(10):2028-34. DOI: 10.1016/j.ophtha.2011.02.034</RefTotal> <RefLink>https://doi.org/10.1016/j.ophtha.2011.02.034</RefLink> </Reference> <Reference refNo="7"> <RefAuthor>Basak SK</RefAuthor> <RefAuthor>Deolekar SS</RefAuthor> <RefAuthor>Mohanta A</RefAuthor> <RefAuthor>Banerjee S</RefAuthor> <RefAuthor>Saha S</RefAuthor> <RefTitle>Bacillus cereus infection after Descemet stripping endothelial keratoplasty</RefTitle> <RefYear>2012</RefYear> <RefJournal>Cornea</RefJournal> <RefPage>1068-70</RefPage> <RefTotal>Basak SK, Deolekar SS, Mohanta A, Banerjee S, Saha S. Bacillus cereus infection after Descemet stripping endothelial keratoplasty. Cornea. 2012;31(9):1068-70. DOI: 10.1097/ICO.0b013e31823f0b49</RefTotal> <RefLink>https://doi.org/10.1097/ICO.0b013e31823f0b49</RefLink> </Reference> <Reference refNo="8"> <RefAuthor>Akkach S</RefAuthor> <RefAuthor>Thet MKK</RefAuthor> <RefTitle>Corneal ring infiltrate secondary to Staphylococcus aureus-induced endogenous endophthalmitis: a case report</RefTitle> <RefYear>2018</RefYear> <RefJournal>Clin Exp Ophthalmol</RefJournal> <RefPage>92-4</RefPage> <RefTotal>Akkach S, Thet MKK. Corneal ring infiltrate secondary to Staphylococcus aureus-induced endogenous endophthalmitis: a case report. Clin Exp Ophthalmol. 2018;46(1):92-4. DOI: 10.1111/ceo.13005</RefTotal> <RefLink>https://doi.org/10.1111/ceo.13005</RefLink> </Reference> <Reference refNo="9"> <RefAuthor>Zamora KV</RefAuthor> <RefAuthor>Males JJ</RefAuthor> <RefTitle>Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report</RefTitle> <RefYear>2009</RefYear> <RefJournal>Cornea</RefJournal> <RefPage>474-6</RefPage> <RefTotal>Zamora KV, Males JJ. Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea. 2009;28(4):474-6. DOI: 10.1097/ICO.0b013e31818d381a</RefTotal> <RefLink>https://doi.org/10.1097/ICO.0b013e31818d381a</RefLink> </Reference> </References> <Media> <Tables> <NoOfTables>0</NoOfTables> </Tables> <Figures> <Figure width="487" height="384" format="png"> <MediaNo>1</MediaNo> <MediaID>1</MediaID> <Caption><Pgraph><Mark1>Figure 1: Slit-lamp examination of the eye demonstrating diffuse conjunctival injection, corneal ring infiltrate and vitreous haze</Mark1></Pgraph></Caption> </Figure> <Figure width="596" height="490" format="png"> <MediaNo>2</MediaNo> <MediaID>2</MediaID> <Caption><Pgraph><Mark1>Figure 2: B-scan ultrasonography showing dense opacity throughout the vitreous cavity with attached retina</Mark1></Pgraph></Caption> </Figure> <NoOfPictures>2</NoOfPictures> </Figures> <InlineFigures> <NoOfPictures>0</NoOfPictures> </InlineFigures> <Attachments> <NoOfAttachments>0</NoOfAttachments> </Attachments> </Media> </OrigData> </GmsArticle>